US recalls India-made birth control pills

A batch of birth control pills manufactured in India for US distribution has been recalled due to a packaging error that could make the pills ineffective, US health authorities said on Monday.

Seven lots of generic norgestimate and ethinyl estradiol tablets were recalled by Glenmark Generics Inc. USA, the US said.

The company said the tablets were manufactured and packaged by Glenmark Generics Ltd. India. and distributed to wholesalers and across the United States between September 21, 2011 and December 30, 2011.

"As a result of this packaging error, the daily regimen for these may be incorrect and could leave women without adequate contraception, and at risk for ," Glenmark said in a statement.

It was not immediately clear how many packets were affected by the error, which rotated some of the pills by 180 degrees out of the usual sequential order and left the lot number and expiry date visible only on the outer pouch.

"Any blister for which the lot number and expiry date is not visible is subject to recall," Glenmark added in a statement.

Doctors urged women who may have been taking the pills to immediately begin using a non-hormonal form of contraception, inform their immediately and take a if they have any symptoms of pregnancy.

"This is extremely disturbing," said Steven Goldstein, an obstetrician-gynecologist at New York University Langone Medical Center and Professor at the NYU School of Medicine, adding the recall raised new concerns about the safety of foreign-made generics.

"This problem with generics manufactured outside of the USA is of great concern to me as a clinician. I often allow and encourage patients to try generics as long as they do not have nuisance side effects however I have always assumed them of equal quality control to the branded products."

Glenmark Generics has operated its manufacturing plant in India since 2003.

The recall is the third to affect US consumers in the past six months involving contraceptives.

On February 1, US pharmaceutical giant Pfizer recalled one million packets of over a similar packaging error, though those pills were manufactured in the United States.

A separate recall was issued in September 2011 by the pharmaceutical company Qualitest in Alabama, due to packaging errors that affected 1.4 million packets of birth control pills distributed in 2011.

add to favorites email to friend print save as pdf

Related Stories

US reviews birth control pill safety over clot risk

May 31, 2011

The US Food and Drug Administration said Tuesday it is reviewing recently published studies which have pointed to an increased blood clot risk associated with a certain type of birth control pill.

Recommended for you

Drug research and development more efficient than expected

6 hours ago

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...

Use new meningitis vaccines only for outbreaks

Feb 26, 2015

(AP)—A U.S. panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

New antibiotic avycaz approved

Feb 26, 2015

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, ...

Tagging drugs to fight counterfeit medicines

Feb 25, 2015

The U.S. and other countries are enacting rules to clamp down on the sales of fake pharmaceuticals, which pose a public health threat. But figuring out a system to track and authenticate legitimate drugs still faces significant ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.